| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; the 2Department of Ophthalmology and the 4Laboratory of Histochemistry and Cytochemistry, University of Leuven, Belgium; and the 3King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
PURPOSE. To investigate the expression of the apoptotic mediators in the retinas from human subjects with diabetes mellitus.
METHODS. Ten donor eyes from five subjects with diabetes mellitus, and eight eyes from four nondiabetic subjects without known ocular disease serving as control subjects were examined. Immunohistochemical techniques were used with antibodies directed against glial fibrillary acidic protein (GFAP), caspase-3, Fas, Fas ligand (FasL), Bax, Bcl-2, survivin, p53, extracellular signal-regulated kinases (ERK1/2), and p38.
RESULTS. In retinas from all subjects without diabetes, weak Bcl-2 immunoreactivity was confined to GFAP-positive glial cells in the nerve fiber layer. Weak immunoreactivity for ERK1/2 was noted in a few nuclei in the inner nuclear layer and in a few Müller cell processes. Cytoplasmic immunostaining for survivin was noted in the retinal pigment epithelial cells. There was no immunoreactivity for the other antibodies tested. All diabetic retinas showed cytoplasmic immunoreactivity for caspase-3, Fas, and Bax in ganglion cells. FasL immunoreactivity was detected in GFAP-positive cells. Upregulation of Bcl-2 immunoreactivity was noted in GFAP-positive cells in nerve fiber and ganglion cell layers, and Bcl-2 induction was noted in Müller cell processes. Strong immunoreactivity for ERK1/2 was observed in many nuclei in the inner nuclear layer in GFAP-positive cells in the nerve fiber and ganglion cell layers and numerous Müller cell processes. Survivin immunoreactivity was not altered in the diabetic retinas. There was no immunoreactivity for p53 and p38.
CONCLUSIONS. Ganglion cells in diabetic retinas express several proapoptosis molecules, suggesting that these cells are the most vulnerable population. Glial cells in diabetic retinas are activated and express several antiapoptosis molecules in addition to the cytotoxic effector molecule FasL, suggesting a possible role of glial cells in induction of apoptosis in ganglion cells.
This article has been cited by other articles:
|
|
 |
|
  T. S. Kern and A. J. Barber Retinal ganglion cells in diabetes J. Physiol., September 15, 2008; 586(18): 4401 - 4408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Smith, J. Duplantier, Y. Dun, B. Mysona, P. Roon, P. M. Martin, and V. Ganapathy In Vivo Protection against Retinal Neurodegeneration by Sigma Receptor 1 Ligand (+)-Pentazocine Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4154 - 4161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kohzaki, A. J. Vingrys, and B. V. Bui Early Inner Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3595 - 3604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Field, V. M. Elner, D. G. Puro, J. M. Feuerman, D. C. Musch, R. Pop-Busui, R. Hackel, J. R. Heckenlively, and H. R. Petty Rapid, Noninvasive Detection of Diabetes-Induced Retinal Metabolic Stress Arch Ophthalmol, July 1, 2008; 126(7): 934 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Gastinger, A. R. Kunselman, E. E. Conboy, S. K. Bronson, and A. J. Barber Dendrite Remodeling and Other Abnormalities in the Retinal Ganglion Cells of Ins2Akita Diabetic Mice Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2635 - 2642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sancho-Tello, M. Muriach, J. Barcia, F. Bosch-Morell, J. M. Genoves, S. Johnsen-Soriano, B. Romero, I. Almansa, M. Diaz-Llopis, S. Garcia-Delpech, et al. Chronic Alcohol Feeding Induces Biochemical, Histological, and Functional Alterations in Rat Retina Alcohol Alcohol., February 27, 2008; (2008) agn006v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takahashi and E. Chihara Impact of Diabetic Retinopathy on Quantitative Retinal Nerve Fiber Layer Measurement and Glaucoma Screening Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 687 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, Y. Wu, Y. Jin, F. Ji, S. H. Sinclair, Y. Luo, G. Xu, L. Lu, W. Dai, M. Yanoff, et al. Intravitreal Injection of Erythropoietin Protects both Retinal Vascular and Neuronal Cells in Early Diabetes Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 732 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Li, Y. S. Devi, L. Bao, J. Mao, and G. Gibori Involvement of Cyclin D3, CDKN1A (p21), and BIRC5 (Survivin) in Interleukin 11 Stimulation of Decidualization in Mice Biol Reprod, January 1, 2008; 78(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Carrasco, C. Hernandez, A. Miralles, P. Huguet, J. Farres, and R. Simo Lower Somatostatin Expression Is an Early Event in Diabetic Retinopathy and Is Associated With Retinal Neurodegeneration Diabetes Care, November 1, 2007; 30(11): 2902 - 2908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Santiago, S. C. Rosa, P. F. Santos, A. J. Cristovao, A. J. Barber, and A. F. Ambrosio Elevated glucose changes the expression of ionotropic glutamate receptor subunits and impairs calcium homeostasis in retinal neural cells. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4130 - 4137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Antonetti, A. J. Barber, S. K. Bronson, W. M. Freeman, T. W. Gardner, L. S. Jefferson, M. Kester, S. R. Kimball, J. K. Krady, K. F. LaNoue, et al. Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease Diabetes, September 1, 2006; 55(9): 2401 - 2411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Gastinger, R. S. J. Singh, and A. J. Barber Loss of Cholinergic and Dopaminergic Amacrine Cells in Streptozotocin-Diabetic Rat and Ins2Akita-Diabetic Mouse Retinas. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3143 - 3150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fukuda and L. M. Pelus Survivin, a cancer target with an emerging role in normal adult tissues Mol. Cancer Ther., May 1, 2006; 5(5): 1087 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Kramerov, M. Saghizadeh, H. Pan, A. Kabosova, M. Montenarh, K. Ahmed, J. S. Penn, C. K. Chan, D. R. Hinton, M. B. Grant, et al. Expression of Protein Kinase CK2 in Astroglial Cells of Normal and Neovascularized Retina Am. J. Pathol., May 1, 2006; 168(5): 1722 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Georges, E E Cornish, J M Provis, and M C Madigan Muller cell expression of glutamate cycle related proteins and anti-apoptotic proteins in early human retinal development Br. J. Ophthalmol., February 1, 2006; 90(2): 223 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M R Hussein Analysis of Bcl-2 protein expression in choroidal melanomas J. Clin. Pathol., May 1, 2005; 58(5): 486 - 489. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
